Cdc14a phosphatase Activators
Cdc14a phosphatase activators are a unique class of compounds that influence specific signaling pathways to indirectly enhance the functional activity of Cdc14a phosphatase. Okadaic Acid, for instance, is a classical phosphatase inhibitor that targets PP1 and PP2A, creating a cellular environment with elevated phosphorylation. This biochemical shift can enhance the activity of other phosphatases like Cdc14a, which may take on a greater role in dephosphorylating proteins to maintain cellular homeostasis. Similarly, Calyculin A and Cantharidin, by inhibiting PP1 and PP2A, can lead to an increased requirement for Cdc14a phosphatase activity to counteract the resultant hyperphosphorylation.
Furthermore, chemicals like Fostriecin, Microcystin-LR, Tautomycin, and Endothall share a common mechanism by selectively inhibiting PP2A and to a lesser extent PP1, which would indirectly necessitate an upsurge in Cdc14a phosphatase activity. This compensatory mechanism ensures that cellular phosphorylation levels remain balanced, highlighting the critical role of Cdc14a phosphatase in cellular signaling. Compounds such as Ionomycin and Forskolin, which modulate calcium levels and cAMP respectively, also can to indirectlyinfluence Cdc14a phosphatase activity. Ionomycin, by increasing intracellular calcium, can affect calcium-dependent protein kinases and phosphatases, which may indirectly enhance the role of Cdc14a phosphatase in dephosphorylation processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Phosphatase inhibitor that specifically inhibits PP1 and PP2A, leading to increased phosphorylation levels within cells. This indirectly enhances Cdc14a phosphatase activity by upregulating its compensatory role in dephosphorylation processes. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
A potent inhibitor of PP1 and PP2A phosphatases. It increases phosphorylation within the cell, which may indirectly necessitate greater Cdc14a phosphatase activity to restore balance. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
An inhibitor of PP2A and PP1 phosphatases, which induces hyperphosphorylation in the cell. This can enhance the activity of Cdc14a phosphatase as the cell may rely on it more for dephosphorylation to counteract the effects of cantharidin. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
Selectively inhibits PP2A over PP1, leading to a compensatory increase in dephosphorylation activity by Cdc14a phosphatase to maintain cellular phosphorylation balance. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits protein phosphatases PP1 and PP2A, which could indirectly enhance the function of Cdc14a phosphatase by increasing the substrate availability for dephosphorylation. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Acts as a PP2A inhibitor, leading to potential enhancement of Cdc14a phosphatase activity due to increased phosphorylated protein substrates. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, which can modulate various calcium-dependent signaling pathways, indirectly influencing the activity of Cdc14a phosphatase. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, leading to an increase in cAMP and activation of PKA, which can indirectly enhance Cdc14a phosphatase activity through cAMP-dependent signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which can enhance Cdc14a phosphatase activity by increasing the phosphorylation of proteins that may serve as substrates for Cdc14a. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
A bisphosphonate that can affect intracellular signaling pathways related to bone metabolism, potentially indirectly influencing Cdc14a phosphatase activity in osteoclasts. | ||||||